---
title: Recent Posts (8)
description: (8)
---

- [Our Customers and Partners](http://www.congenica.com/our-customers)
- [Our Product Portfolio](http://www.congenica.com/congenica-products) 
    - **Inherited Diseases** 
          - [Rare Disease](http://www.congenica.com/congenica-rare-disease)
          - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer)
          - [Prenatal Health](http://www.congenica.com/congenica-prenatal)
          - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening)
          - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro)
    - **Somatic Oncology** 
          - [Solid Tumours](http://www.congenica.com/congenica-oncology)
    - **Pathogen** 
          - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance)
- [Our Services](http://www.congenica.com/congenica-services) 
    - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services)
    - [Professional Services](http://www.congenica.com/professional-services)
    - [Customer Support](http://www.congenica.com/customer-support)
    - [Pharma Services](http://www.congenica.com/pharma-services)
- Resources 
    - [Publications](http://www.congenica.com/publications)
    - [Supporting materials](http://www.congenica.com/resources)
    - [News](https://blog.congenica.com/)
    - [Events and webinars](http://www.congenica.com/events-webinars)
- [About us](http://www.congenica.com) 
    - [Leadership Team](http://www.congenica.com/leadership)
    - [Quality](http://www.congenica.com/quality)
    - [Investors](http://www.congenica.com/investors)
    - [People and Vacancies](http://www.congenica.com/people)
- [Contact us](http://www.congenica.com/contact)

Login

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

# Latest News and Blogs

![Congenica Receives CE Mark for Genomic Analysis Software](https://blog.congenica.com/hs-fs/hubfs/Canva%20images/Congenica%20is%20now%20a%20CE%20Marked%20medical%20device.png?width=320&height=192&name=Congenica%20is%20now%20a%20CE%20Marked%20medical%20device.png)

 7/21/2021

#### [Congenica Receives CE Mark for Genomic Analysis Software](https://blog.congenica.com/congenica-receives-ce-mark-for-genomic-analysis-software)

Congenica NGS data analysis software for genomic data interpretation is now CE marked under the In Vitro Diagnostics Directive.

![Discovering Glut1 Deficiency Syndrome](https://blog.congenica.com/hs-fs/hubfs/Trudy%20Morgan%2c%20European%20Outreach%20Director%20Glut1%20Deficiency%20Foundation%20and%20Chair%2c%20Glut1%20Deficiency%20UK%20to%20talk%20about%20her%20personal%20discovery%20of%20Glut1%20deficiency%20syndrome..png?width=320&height=192&name=Trudy%20Morgan%2c%20European%20Outreach%20Director%20Glut1%20Deficiency%20Foundation%20and%20Chair%2c%20Glut1%20Deficiency%20UK%20to%20talk%20about%20her%20personal%20discovery%20of%20Glut1%20deficiency%20syndrome..png)

 7/9/2021

#### [Discovering Glut1 Deficiency Syndrome](https://blog.congenica.com/discovering-glut1-deficiency-syndrome)

In recognition of the first International Glut1 Awareness Day, guest blogger Trudy Morgan from Glut1 Deficiency UK talks about her experiences.

![David Atkins welcomes the Government's Life Sciences Sector Vision](https://blog.congenica.com/hs-fs/hubfs/Dr%20Meriel%20McEntagart%2c%20Consultant%20Geneticist%2c%20St%20George%E2%80%99s%20University%20Hospitals%20NHS%20(3).png?width=320&height=192&name=Dr%20Meriel%20McEntagart%2c%20Consultant%20Geneticist%2c%20St%20George%E2%80%99s%20University%20Hospitals%20NHS%20(3).png)

 7/7/2021

#### [David Atkins welcomes the Government's Life Sciences Sector Vision](https://blog.congenica.com/david-atkins-welcomes-governments-life-sciences-sector-vision)

A press release from the UK Bio Industry Association (BIA) welcomes the Government's new Life Sciences Sector Vision and quotes Congenica CEO David Atkins

![Diagnosing CALFAN syndrome after years of uncertainty](https://blog.congenica.com/hs-fs/hubfs/Dr%20Meriel%20McEntagart%2c%20Consultant%20Geneticist%2c%20St%20George%E2%80%99s%20University%20Hospitals%20NHS.png?width=320&height=192&name=Dr%20Meriel%20McEntagart%2c%20Consultant%20Geneticist%2c%20St%20George%E2%80%99s%20University%20Hospitals%20NHS.png)

 7/5/2021

#### [Diagnosing CALFAN syndrome after years of uncertainty](https://blog.congenica.com/diagnosing-calfan-syndrome-after-years-of-uncertainty)

How clinicians used Congenica to diagnose an exceptionally rare condition, providing a diagnosis for a child's medical issues after years of investigation.

![Rapid diagnosis of Long QT syndrome protects family from major health risk](https://blog.congenica.com/hs-fs/hubfs/Add%20a%20subheading%20(1).png?width=320&height=192&name=Add%20a%20subheading%20(1).png)

 6/30/2021

#### [Rapid diagnosis of Long QT syndrome protects family from major health risk](https://blog.congenica.com/rapid-diagnosis-of-long-qt-syndrome-protects-family-from-major-health-risk)

Congenica supports the rapid diagnosis of Long QT syndrome and enables consideration of potentially life-saving interventions for baby and mother.

![Clinical OMICs interview with David Atkins CEO Congenica](https://blog.congenica.com/hs-fs/hubfs/CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png?width=320&height=192&name=CEO%20David%20Atkins%20is%20inteviewed%20for%20Clinical%20OMICs.png)

 6/25/2021

#### [Clinical OMICs interview with David Atkins CEO Congenica](https://blog.congenica.com/clinical-omics-interview-with-david-atkins-ceo-congenica)

Clinical OMICs features an interview with Congenica CEO David Atkins who talks about the genomic medicine landscape and Congenica's plans for the future.

![Raising awareness of Dravet Syndrome](https://blog.congenica.com/hs-fs/hubfs/Canva%20images/Galia%20Wilson%2c%20mother%20to%20Arlo%2c%20a%2013-year%20old%20boy%20with%20Dravet%20Syndrome%2c%20and%20Chair%20and%20Trustee%20of%20DSUK.png?width=320&height=192&name=Galia%20Wilson%2c%20mother%20to%20Arlo%2c%20a%2013-year%20old%20boy%20with%20Dravet%20Syndrome%2c%20and%20Chair%20and%20Trustee%20of%20DSUK.png)

 6/23/2021

#### [Raising awareness of Dravet Syndrome](https://blog.congenica.com/raising-awareness-of-dravet-syndrome)

Galia Wilson and Claire Eldred have provided us with today's article in recognition of International Dravet Syndrome Awareness day, Wednesday 23rd June. 

![Genomics in the Clinic & the Promise of Precision Medicine](https://blog.congenica.com/hs-fs/hubfs/Hear%20the%20panel%20session%20from%20PMLS%20Precision%20Medicine%20%26%20Rare%20Disease%20event.png?width=320&height=192&name=Hear%20the%20panel%20session%20from%20PMLS%20Precision%20Medicine%20%26%20Rare%20Disease%20event.png)

 6/22/2021

#### [Genomics in the Clinic & the Promise of Precision Medicine](https://blog.congenica.com/genomics-in-the-clinic-the-promise-of-precision-medicine)

At PMLS Precision Medicine and Rare Disease event, Congenica took part in a panel entitled 'Genomics in the Clinic and the Promise of Precision Medicine'.

![Our story of Norrie Disease](https://blog.congenica.com/hs-fs/hubfs/NorrieDisease2.jpg?width=320&height=192&name=NorrieDisease2.jpg)

 6/18/2021

#### [Our story of Norrie Disease](https://blog.congenica.com/our-story-of-norrie-disease)

We welcome guest blogger Carla Golledge, who shares her story about son Cameron who was born with Norrie disease. 

![Congenica funded to reduce fatal drug interactions by mapping genes](https://blog.congenica.com/hs-fs/hubfs/Blog%20Congenica%20awarded%20%C2%A32%20million%20to%20develop%20new%20pharmacogenetics%20software%20to%20prevent%20fatal%20drug%20interactions.png?width=320&height=192&name=Blog%20Congenica%20awarded%20%C2%A32%20million%20to%20develop%20new%20pharmacogenetics%20software%20to%20prevent%20fatal%20drug%20interactions.png)

 6/17/2021

#### [Congenica funded to reduce fatal drug interactions by mapping genes](https://blog.congenica.com/ukri-and-lg-fund-congenica-to-reduce-fatal-drug-interactions-by-mapping-genes)

New software to reduce the number of adverse drug reactions is being developed thanks to a joint investment of £2 million provided by UKRI and L& G.

![The challenges and opportunities for growth during a global pandemic](https://blog.congenica.com/hs-fs/hubfs/Canva%20images/Andy%20Richards%2c%20Chairman%20Congenica.png?width=320&height=192&name=Andy%20Richards%2c%20Chairman%20Congenica.png)

 6/17/2021

#### [The challenges and opportunities for growth during a global pandemic](https://blog.congenica.com/the-challenges-and-opportunities-for-growth-during-a-global-pandemic)

Congenica's Chairman Andy Richards and CEO David Atkins join leaders from biotech / pharma sector to discuss the impact of pandemic in the last 18 months.

![Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases](https://blog.congenica.com/hs-fs/hubfs/Congenica%20helps%20Veritas%20Genetics%20serve%20clients%20and%20solve%20clinical%20cases.png?width=320&height=192&name=Congenica%20helps%20Veritas%20Genetics%20serve%20clients%20and%20solve%20clinical%20cases.png)

 6/15/2021

#### [Enhanced whole exome analysis enables Veritas Intercontinental to solve more cases](https://blog.congenica.com/congenica-helps-veritas-genetics-serve-clients-solve-clinical-cases)

Veritas Genetics partnered with Congenica to improve diagnostic yield & increase the efficiency, throughput and speed of analysis in diagnostic laboratory

##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.

- [Privacy Policy](http://www.congenica.com/privacy-policy)
- [Cookie Policy](http://www.congenica.com/cookie-policy)

<https://twitter.com/congenica> <https://en-gb.facebook.com/congenica/> <https://www.linkedin.com/company/congenica/> 

Log in to Congenica

##### Please select your location and reference genome:

[America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/)

![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark_9000030872_EN_2024_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png)

Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.